Antibodies to PECI have been found in patients with autoimmune diabetes [35], breast cancer[36], renal cancer [37], and hepatocarcinoma [38] and PECI serves as an autoantigen eliciting immune attack against hematopoietic progenitor cells by both T and B cells in acquired aplastic anemia patients [39]. Here, ECI2 is linked to breast cancer.